HPV Newsletters

Insight HPV for OB/GYNs - Winter 2006

Issue Date: January 3, 2006    Expires: January 3, 2009

In this issue of Insight HPV, we review several case studies that illustrate the appropriate application of HPV DNA testing, new screening recommendations, and the identification of vaginal lesions.

This program is designated for a maximum of 0.5 credits in category 1 of the Physician's Recognition Award of the American Medical Association.

Release Date: January 3, 2006
Expiration Date: January 3, 2009

Learning Objectives

After reading this publication, the participant should be able to:

• Identify knowledge gaps about STDs and HPV within the patient population;
• Understand the importance of patient education in the prevention of HPV infection and transmission;
• Provide patients with several educational resources and a clear understanding of how HPV is contracted, transmitted, and prevented; and
• Identify HPV management and prevention strategies including the use of new vaccines.

Faculty

Jeffrey Lin, MD, FACOG

Associate Professor
Director, Divisions of Gynecologic Oncology and General Obstetrics and Gynecology Chief, Gynecologic Surgery
The George Washington University Medical Center
Washington, DC

Henry Buck, MD

Head, Gynecology
Watkins Memorial Health Center
University of Kansas
Lawrence, KS
Disclosures: Dr. Buck has received grant/research support from Merck Research Laboratories and served as a consultant to 3M Pharmaceuticals and Merck & Co. Dr. Buck has participated in speakers' bureaus for 3M Pharmaceuticals, Digene, and TriPath, and has served on an advisory board for Merck & Co.

Jennifer Gunter, MD

Assistant Professor of Obstetrics and Gynecology
Associate Professor of Anesthesiology
University of Colorado, Health Science Center
Denver, CO
Disclosures: Dr. Gunter has received honoraria and grant support from Allergan, 3M pharmaceuticals, and Persutti Labs.

Stanley Gall, MD

Donald E. Baxter Professor and Chairman Emeritus Department of Obstetrics and Gynecology University of Louisville Health Sciences Center Louisville, KY
Disclosures: Dr. Gall has received grant/research support from and served as a consultant to Merck & Co., GlaxoSmithKline and 3M Pharmaceuticals. Dr. Gall has participated in speakers' bureaus for Merck & Co., 3M Pharmaceuticals and Pfizer and has served on advisory boards for Merck & Co. and GlaxoSmithKline.

Kevin A. Ault, MD

Associate Professor
Department of Obstetrics and Gynecology
Emory University
Woodruff Health Sciences Center
Atlanta, GA
Disclosures: Dr. Ault has received grant/research support from Merck & Co., GlaxoSmithKline, 3M, and Procter & Gamble Pharmaceuticals. Dr. Ault has served as a consultant to Merck & Co., 3M, and GlaxoSmithKline. Dr. Ault also has served on an advisory board for Merck & Co.

About this CME Activity

This CME activity was planned and produced in accordance with the ACCME's Essential Areas, Elements and Policies. The George Washington University Medical Center designates this educational activity for a maximum of .5 credits in category 1 of the AMA Physicians' Recognition Award. Each physician should claim only those hours of credit that he or she actually spent in the educational activity.